Cargando…
LPCAT1 acts as an independent prognostic biomarker correlated with immune infiltration in hepatocellular carcinoma
BACKGROUND: Lysophosphatidylcholine acyltransferase 1 (LPCAT1) is overexpressed in multiple human tumors. However, the role of LPCAT1 in hepatocellular carcinoma (HCC) has not been understood. We aim to explore the relationships between LPCAT1 expression and prognosis, clinicopathological features,...
Autores principales: | Li, Lan, Wang, Xiao, Ding, Yanni, Hui, Nini, Su, Bingjie, Yang, Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9617428/ https://www.ncbi.nlm.nih.gov/pubmed/36307879 http://dx.doi.org/10.1186/s40001-022-00854-1 |
Ejemplares similares
-
Comprehensive Analysis of LPCATs Highlights the Prognostic and Immunological Values of LPCAT1/4 in Hepatocellular Carcinoma
por: Lin, Tong, et al.
Publicado: (2021) -
LPCAT3 is a potential prognostic biomarker and may be correlated with immune infiltration and ferroptosis in acute myeloid leukemia: a pan-cancer analysis
por: Ke, Peng, et al.
Publicado: (2022) -
ncRNA-Mediated High Expression of LPCAT1 Correlates with Poor Prognosis and Tumor Immune Infiltration of Liver Hepatocellular Carcinoma
por: Sun, Qiu, et al.
Publicado: (2022) -
LPCAT1 functions as a novel prognostic molecular marker in hepatocellular carcinoma
por: Zhang, Hongbin, et al.
Publicado: (2020) -
Pan-cancer analysis identifies LPCATs family as a prognostic biomarker and validation of LPCAT4/WNT/β-catenin/c-JUN/ACSL3 in hepatocellular carcinoma
por: Lu, Yaoyong, et al.
Publicado: (2023)